BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6797699)

  • 1. Bone turnover in Paget's disease: biochemical and kinetic measurements during salmon calcitonin therapy.
    Hosking DJ; Vennart W; Huddlestone LB
    Calcif Tissue Int; 1981; 33(5):471-6. PubMed ID: 6797699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New method of measuring total and regional bone fixation of calcium in patients with Paget's disease treated with salmon calcitonin].
    Bergmann P; Schoutens A; Corvilain J
    Strahlentherapie Sonderb; 1975; 74():301-8. PubMed ID: 1239103
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.
    Avramides A; Baker RK; Wallach S
    Metabolism; 1974 Nov; 23(11):1037-46. PubMed ID: 4472557
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.
    Oreopoulos DG; Husdan H; Harrison J; Meema HE; McNeill KG; Murray TM; Ogilvie R; Rapoport A
    Can Med Assoc J; 1977 Apr; 116(8):851-5. PubMed ID: 856428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variations in parathormone serum levels during treatment of Paget's disease with calcitonin of human or salmon origin (author's transl)].
    Heynen G; Franchimont P; Gaspar S; Gysen P; Kanis JA
    Ann Endocrinol (Paris); 1981; 42(3):265-75. PubMed ID: 7316460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Effect of salmon calcitonin treatment on bone turnover, cardiac output and oxygen transport in patients with Paget's disease.
    Crosbie WA; Woodhouse NJ
    Clin Sci Mol Med; 1974 Aug; 47(2):5P-6P. PubMed ID: 4472253
    [No Abstract]   [Full Text] [Related]  

  • 7. Skeletal turnover and total body elemental composition during extended calcitonin treatment of Paget's disease.
    Wallach S; Avramides A; Flores A; Bellavia J; Cohn S
    Metabolism; 1975 Jun; 24(6):745-53. PubMed ID: 1128238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term treatment of Paget's disease of bone with salmon calcitonin.
    Sturtridge WC; Harrison JE; Wilson DR
    Can Med Assoc J; 1977 Nov; 117(9):1031-4. PubMed ID: 562231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget's disease before and after calcitonin treatment.
    Waxman AD; Ducker S; McKee D; Siemsen JK; Singer FR
    Radiology; 1977 Dec; 125(3):761-4. PubMed ID: 928705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional significance of antibody formation after long-term salmon calcitonin therapy.
    Hosking DJ; Denton LB; Cadge B; Martin TJ
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):243-52. PubMed ID: 572275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic and metabolic investigations in Paget's disease of bone, assessment of human synthetic calcitonin therapy.
    Reiner M; Woodhouse NJ; Kalu DN; Foster GV; Galante L; Joplin GF; MacIntyre I
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:136. PubMed ID: 5288785
    [No Abstract]   [Full Text] [Related]  

  • 12. Human calcitonin treatment of Paget's disease of bone.
    Singer FR
    Clin Orthop Relat Res; 1977; (127):86-93. PubMed ID: 912995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the acute effects of subcutaneous and intranasal calcitonin.
    O'Doherty DP; Bickerstaff DR; McCloskey EV; Atkins R; Hamdy NA; Kanis JA
    Clin Sci (Lond); 1990 Feb; 78(2):215-9. PubMed ID: 2155751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical and metabolic effects of porcine calcitonin on Paget's disease of bone.
    Shai F; Baker RK; Wallach S
    J Clin Invest; 1971 Sep; 50(9):1927-40. PubMed ID: 4935444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmon and porcine calcitonin treatment of Paget's disease of bone.
    Avramides A
    Clin Orthop Relat Res; 1977; (127):78-85. PubMed ID: 303164
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of calcitonin treatment on the natural course of bone demineralization in Paget's disease.
    Toh SH; Claunch BC; Brown PH
    J Clin Endocrinol Metab; 1983 Feb; 56(2):405-9. PubMed ID: 6822644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of salmon calcitonin on cardiac output, oxygen transport and bone turnover in patients with Paget's disease.
    Crosbie WA; Mohamedally SM; Woodhouse NJ
    Clin Sci Mol Med Suppl; 1975 Jun; 48(6):537-40. PubMed ID: 1056285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human calcitonin in the treatment of Paget's bone disease.
    Woodhouse NJ; Bordier P; Fisher M; Joplin GF; Reiner M; Kalu DN; Foster GV; MacIntyre I
    Lancet; 1971 Jun; 1(7710):1139-43. PubMed ID: 4102856
    [No Abstract]   [Full Text] [Related]  

  • 19. Paget's bone disease: response to human calcitonin in patients resistant to salmon calcitonin.
    Rojanasathit S; Rosenberg E; Haddad JG
    Lancet; 1974 Dec; 2(7894):1412-5. PubMed ID: 4140329
    [No Abstract]   [Full Text] [Related]  

  • 20. Early effects of calcitonin on urinary excretion of calcium and 47calcium in Paget's disease.
    Gennari C; Vattimo A
    J Nucl Biol Med; 1975; 19(2):73-9. PubMed ID: 1165495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.